Supplementary Table 2 Sensitivity of colorectal cancer cell lines to the Erlotinib EGFR inhibitor.

From: RasGRP1 opposes proliferative EGFR–SOS1–Ras signals and restricts intestinal epithelial cell growth

EC50 values for the anti-EGFR inhibitor Erlotinib in 14 colorectal cancer cell lines and the EGFR-negative T cell lymphoma cell line Jurkat. Extracted with permission from the CCLE—Cancer Cell Line Encyclopedia, a collaborative initiative between the Broad Institute and Novartis.
Back to article page